A recent study led by the Department of Medicine, School of Clinical Medicine, LKS Faculty of Medicine of the University of Hong Kong (HKUMed), in collaboration with the Correctional Services Department, has demonstrated that mass screening for hepatitis C virus (HCV) infection among persons in custody (PICs) is a cost-effective strategy. By enabling early identification and treatment of infected PICs, this approach can offer measurable health benefits. The data provide strong evidence to support the implementation of systematic prison-based HCV screening in Hong Kong. The findings are published in The Lancet Regional Health—Western Pacific.
Cost-Effectiveness of Mass Hepatitis C Screening in Custody: Implications for Health Policy
A study from the University of Hong Kong confirms that mass screening for hepatitis C virus among persons in custody is cost-effective, highlighting the importance of early detection and treatment. This research, published in The Lancet Regional Health, could influence health policies in similar contexts, including Iran's prison system. The findings emphasize the need for systematic health interventions in correctional facilities.
👥 Key Players
📰 What Happened
A study found that mass screening for hepatitis C among incarcerated individuals is cost-effective, promoting early detection and treatment. This research supports implementing systematic HCV screening in Hong Kong's prisons.
- The study was published in The Lancet Regional Health—Western Pacific.
- It highlights the health benefits of early identification and treatment of hepatitis C in custody.
💡 Why It Matters
📚 Background
Hepatitis C is a major public health issue, particularly in prison populations where the risk of transmission is higher. Mass screening can lead to better health outcomes and reduce overall healthcare costs.
🏷️ Entities Mentioned
Translated from the original and edited for English readers. View original source →
Translation confidence: 100%